[Asia Economy Reporter Ji Yeon-jin] Celltrion Healthcare announced on the 4th that its sales revenue last year reached 1,627.5 billion KRW, an increase of 47.8% compared to the previous year. Operating profit increased by 337.4% to 362.1 billion KRW, and net profit for the period rose by 270.1% to 240.4 billion KRW.



The company explained, "Sales revenue increased by 47.8% compared to the previous year due to stable sales generation in the European market and the expansion of market share for Inflectra and Truxima in the US market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing